Natera NTRA
NASDAQ NTRA
$366.36 +21.02 (+6.08%)
As of: Sep 17, 2026 · 3:59 PM EDT

Natera (NTRA) EBITDA Margin Growth (3y) (2017 - 2026)

Analysis

Natera (NTRA) EBITDA Margin Growth (3y) (2017 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin Growth (3y) (Qtr)
1 Natera 49.39 Bn 48.29 Bn 486.15 Mn 3,294.00
2 Quest Diagnostics 27.49 Bn 26.86 Bn 1.03 Bn 20.00
3 Labcorp Holdings 26.51 Bn 26.37 Bn 1.11 Bn 333.00
4 Guardant Health 23.17 Bn 22.12 Bn 219.03 Mn 4,867.00
5 Tempus AI 12.59 Bn 11.77 Bn 274.25 Mn 1,424.00
6 Caris Life Sciences 8.01 Bn 7.22 Bn 182.38 Mn -
7 Sotera Health 5.53 Bn 5.17 Bn 177.96 Mn 941.00
8 BillionToOne 4.80 Bn 4.25 Bn 77.11 Mn -
9 Adaptive Biotechnologies 4.40 Bn 4.05 Bn 51.39 Mn 2,869.00
10 iRhythm Holdings 3.68 Bn 3.08 Bn 163.21 Mn 1,407.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3,294.00
Mar 31, 2026 4,378.00
Dec 31, 2025 6,183.00
Sep 30, 2025 4,004.00
Jun 30, 2025 5,200.00
Mar 31, 2025 5,486.00
Dec 31, 2024 6,712.00
Sep 30, 2024 8,605.00
Jun 30, 2024 7,056.00
Mar 31, 2024 2,116.00
Dec 31, 2023 3,865.00
Sep 30, 2023 1,547.00
Jun 30, 2023 1,673.00
Mar 31, 2023 -2,011.00
Dec 31, 2022 -2,344.00
Sep 30, 2022 -2,944.00
Jun 30, 2022 -3,368.00
Mar 31, 2022 -2,313.00
Dec 31, 2021 -3,633.00
Sep 30, 2021 -5,338.00